𝔖 Bobbio Scriptorium
✦   LIBER   ✦

CDDO-imidazolide mediated inhibition of malignant cell growth in Waldenström macroglobulinemia

✍ Scribed by Sherine F. Elsawa; Anne J. Novak; Deanna Grote; Marina Konopleva; Michael Andreeff; Thomas E. Witzig; Stephen M. Ansell

Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
683 KB
Volume
32
Category
Article
ISSN
0145-2126

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vitamin K enhancement of sorafenib-media
Vitamin K enhancement of sorafenib-mediated HCC cell growth inhibition in vitro and in vivo
✍ Gang Wei; Meifang Wang; Terry Hyslop; Ziqiu Wang; Brian I. Carr 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 775 KB

## Abstract The multikinase inhibitor sorafenib is the first oral agent to show activity against human hepatocellular carcinoma (HCC). Apoptosis has been shown to be induced in HCC by several agents, including sorafenib as well as by the naturally occurring K vitamins (VKs). As few nontoxic agents

Involvement of ATM-mediated Chk1/2 and J
Involvement of ATM-mediated Chk1/2 and JNK kinase signaling activation in HKH40A-induced cell growth inhibition
✍ Ziqiu Wang; Meifang Wang; Sid Kar; Brian I. Carr 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 308 KB

## Abstract HKH40A (RTA 502), or 5‐nitro‐2‐(3‐{4‐[3‐(8‐methoxy‐6‐oxo‐6H‐2,10b‐diaza‐aceanthrylen‐5‐ylamino)propyl]piperazin‐1‐yl}‐propyl)‐2‐aza‐phenalene‐1,3‐dione, has been shown to be a potent cell growth inhibitor. To investigate HKH40A actions, we focused on exploring the signal transduction pa